round co-led by Panacea Venture, CTI Life Sciences and 3B Future Health Fund, and joined by adMare BioInnovations , Schroders Capital, Omnes, Turenne Capital, Theodorus, Viva BioInnovator and existing investor Seventure

to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences adMare Academy's BioInnovation

University of Oxford announce partnership to develop treatments for Alzheimer’s disease The adMare Academy Bioinnovation